Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer

Aspirin is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has a recognized role in cancer prevention as well as evidence to support its use as an adjuvant for cancer treatment. Importantly there has been an increasing number of studies contributing to the mechanistic understanding of...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ashley J. Hoskin, Amy K. Holt, Danny N. Legge, Tracey J. Collard, Ann C. Williams, Emma E. Vincent
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Open Exploration Publishing Inc. 2023-08-01
Saila:	Exploration of Targeted Anti-tumor Therapy
Gaiak:	aspirin cancer metabolism metabolic hallmark colorectal cancer cancer prevention nonsteroidal anti-inflammatory drugs adjuvant for therapy anti-tumour
Sarrera elektronikoa:	https://www.explorationpub.com/Journals/etat/Article/1002155
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!